Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Current Taxes: 2015-2018

Historic Current Taxes for Enanta Pharmaceuticals (ENTA) over the last 3 years, with Sep 2018 value amounting to $1.4 million.

  • Enanta Pharmaceuticals' Current Taxes fell 42.89% to $5.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $5.9 million, marking a year-over-year decrease of 42.89%. This contributed to the annual value of $1.4 million for FY2018, which is 85.07% down from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Current Taxes stood at $1.4 million for FY2018, which was down 85.07% from $9.3 million recorded in FY2017.
  • Enanta Pharmaceuticals' 5-year Current Taxes high stood at $9.3 million for FY2017, and its period low was $1.2 million during FY2015.
  • Over the past 2 years, Enanta Pharmaceuticals' median Current Taxes value was $5.3 million (recorded in 2017), while the average stood at $5.3 million.
  • Data for Enanta Pharmaceuticals' Current Taxes shows a maximum YoY tumbled of 85.07% (in 2018) over the last 5 years.
  • Over the past 3 years, Enanta Pharmaceuticals' Current Taxes (Yearly) stood at $1.2 million in 2015, then reached $9.3 million in 2017, then tumbled by 85.07% to $1.4 million in 2018.